These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11358674)

  • 1. Growth hormone activates renin-aldosterone system in children with idiopathic short stature and in a pseudohypoaldosteronism patient with a mutation in epithelial sodium channel alpha subunit.
    Hanukoglu A; Belutserkovsky O; Phillip M
    J Steroid Biochem Mol Biol; 2001 Apr; 77(1):49-57. PubMed ID: 11358674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes.
    Hanukoglu A; Edelheit O; Shriki Y; Gizewska M; Dascal N; Hanukoglu I
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):268-74. PubMed ID: 18634878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and the renin-angiotensin-aldosterone system in children receiving recombinant human growth hormone.
    Barton JS; Hindmarsh PC; Preece MA; Brook CG
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):245-51. PubMed ID: 8458096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized growth hormone substitution with normalized IGF-I levels does not stimulate the renin-angiotensin-aldosterone system.
    Ekman B; Ohman PK; Arnqvist HJ; Lindström T; Nyström FH
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):473-9. PubMed ID: 12354129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body fluid expansion in acromegaly is related to enhanced epithelial sodium channel (ENaC) activity.
    Kamenicky P; Blanchard A; Frank M; Salenave S; Letierce A; Azizi M; Lombès M; Chanson P
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2127-35. PubMed ID: 21508131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism.
    Edelheit O; Hanukoglu I; Gizewska M; Kandemir N; Tenenbaum-Rakover Y; Yurdakök M; Zajaczek S; Hanukoglu A
    Clin Endocrinol (Oxf); 2005 May; 62(5):547-53. PubMed ID: 15853823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Water and sodium retention during short-term administration of growth hormone to short normal children.
    Lampit M; Nave T; Hochberg Z
    Horm Res; 1998; 50(2):83-8. PubMed ID: 9701701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of salt-wasting disorders of adrenal and renal origin.
    Rösler A
    J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism.
    Bonny O; Knoers N; Monnens L; Rossier BC
    Pediatr Nephrol; 2002 Oct; 17(10):804-8. PubMed ID: 12376807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoaldosteronism: decreased aldosterone levels with age without significant change in urinary sodium excretion.
    Yasuda T; Noda-Cho H; Nishioka T; Sasaki N; Niimi H; Nakajima H
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):311-8. PubMed ID: 3519007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel splice site mutation of the beta subunit gene of epithelial sodium channel (ENaC) in one Turkish patient with a systemic form of pseudohypoaldosteronism Type 1.
    Dogan CS; Erdem D; Mesut P; Merve A; Sema A; Iffet B; Afig B
    J Pediatr Endocrinol Metab; 2012; 25(9-10):1035-9. PubMed ID: 23426840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of autosomal recessive Pseudohypoaldosteronism1 ENaC with aldosterone.
    Shabbir W; Topcagic N; Aufy M
    Eur J Pharmacol; 2021 Jun; 901():174090. PubMed ID: 33831414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult nephron-specific MR-deficient mice develop a severe renal PHA-1 phenotype.
    Canonica J; Sergi C; Maillard M; Klusonova P; Odermatt A; Koesters R; Loffing-Cueni D; Loffing J; Rossier B; Frateschi S; Hummler E
    Pflugers Arch; 2016 May; 468(5):895-908. PubMed ID: 26762397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel.
    Gründer S; Firsov D; Chang SS; Jaeger NF; Gautschi I; Schild L; Lifton RP; Rossier BC
    EMBO J; 1997 Mar; 16(5):899-907. PubMed ID: 9118951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous mice.
    Wang Q; Hummler E; Maillard M; Nussberger J; Rossier BC; Brunner HR; Burnier M
    Kidney Int; 2001 Jun; 59(6):2216-21. PubMed ID: 11380824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel alpha-, beta-, and gamma-subunit genes.
    Saxena A; Hanukoglu I; Saxena D; Thompson RJ; Gardiner RM; Hanukoglu A
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3344-50. PubMed ID: 12107247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of ENaC in salt-sensitive hypertension.
    Hummler E
    J Steroid Biochem Mol Biol; 1999; 69(1-6):385-90. PubMed ID: 10419016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
    Rogol AD; Blethen SL; Sy JP; Veldhuis JD
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term growth hormone (GH) treatment of GH-deficient adults increases body sodium and extracellular water, but not blood pressure.
    Hoffman DM; Crampton L; Sernia C; Nguyen TV; Ho KK
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1123-8. PubMed ID: 8772586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.